Multiple sclerosis : clinical and laboratory research
-
Randomized Controlled Trial Multicenter Study
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Bladder dysfunction is a common feature of multiple sclerosis (MS). ⋯ Although the primary endpoint did not reach statistical significance, we conclude that Sativex did have some impact on the symptoms of overactive bladder in patients with MS, providing evidence of some improvement in symptoms associated with bladder dysfunction in these subjects.